1. Home
  2. RCUS vs ALG Comparison

RCUS vs ALG Comparison

Compare RCUS & ALG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCUS
  • ALG
  • Stock Information
  • Founded
  • RCUS 2015
  • ALG 1955
  • Country
  • RCUS United States
  • ALG United States
  • Employees
  • RCUS N/A
  • ALG N/A
  • Industry
  • RCUS Biotechnology: Pharmaceutical Preparations
  • ALG Industrial Machinery/Components
  • Sector
  • RCUS Health Care
  • ALG Industrials
  • Exchange
  • RCUS Nasdaq
  • ALG Nasdaq
  • Market Cap
  • RCUS 2.4B
  • ALG 2.4B
  • IPO Year
  • RCUS 2018
  • ALG 1993
  • Fundamental
  • Price
  • RCUS $19.94
  • ALG $162.75
  • Analyst Decision
  • RCUS Buy
  • ALG Buy
  • Analyst Count
  • RCUS 8
  • ALG 2
  • Target Price
  • RCUS $27.63
  • ALG $225.00
  • AVG Volume (30 Days)
  • RCUS 1.8M
  • ALG 106.5K
  • Earning Date
  • RCUS 10-28-2025
  • ALG 11-06-2025
  • Dividend Yield
  • RCUS N/A
  • ALG 0.74%
  • EPS Growth
  • RCUS N/A
  • ALG N/A
  • EPS
  • RCUS N/A
  • ALG 9.64
  • Revenue
  • RCUS $240,000,000.00
  • ALG $1,615,388,000.00
  • Revenue This Year
  • RCUS N/A
  • ALG $1.20
  • Revenue Next Year
  • RCUS N/A
  • ALG $5.52
  • P/E Ratio
  • RCUS N/A
  • ALG $16.92
  • Revenue Growth
  • RCUS N/A
  • ALG N/A
  • 52 Week Low
  • RCUS $6.50
  • ALG $157.07
  • 52 Week High
  • RCUS $22.11
  • ALG $233.29
  • Technical
  • Relative Strength Index (RSI)
  • RCUS 64.34
  • ALG 27.72
  • Support Level
  • RCUS $19.33
  • ALG $159.66
  • Resistance Level
  • RCUS $20.99
  • ALG $168.89
  • Average True Range (ATR)
  • RCUS 1.17
  • ALG 5.83
  • MACD
  • RCUS -0.19
  • ALG -0.76
  • Stochastic Oscillator
  • RCUS 43.93
  • ALG 15.01

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

About ALG Alamo Group Inc.

Alamo Group Inc is engaged in the design, manufacture, and servicing of high-quality vegetation management and infrastructure maintenance equipment for governmental, industrial and agricultural use. Its products include tractor-mounted and self-propelled mowers, zero-turn mowers, agricultural implements, tree and branch chippers, forestry/wood recycling equipment, street and parking lot sweepers, leaf and debris collection equipment, truck mounted highway attenuator trucks, vacuum trucks, hydro-excavation equipment, telescopic boom excavators, and snow removal equipment. The company's reportable segments are Vegetation Management and Industrial Equipment. It generates a majority of revenue from Vegetation Management. Geographically, it generates the majority of revenue from United States.

Share on Social Networks: